Breakfast Seminar at BIO Convention 2024: Scaling Growth in the US – A Primer for non-US-based Life Sciences Companies

Context:

For life sciences companies based outside the US, contemplating entrance into that vital market can seem exciting and challenging in equal measures. There are a variety of business, financial, and legal factors to be considered which include:

• Engagement with US investors
• How and when to IPO
• Building a workforce 
• Accessing licensing partners for potential collaborations
• Mergers and acquisitions as part of the commercial process.

This panel hosted by Mintz and Mills & Reeve, will address each of the aforementioned and more - while focusing on the current economic environment. 

Panelists:

• Moderator, William Hicks, Co-Chair, Life Sciences Practice, Mintz (William C. Hicks | Member / Co-chair, Securities & Capital Markets | Mintz)
• Michael Jiang, Senior Managing Director in the Equity Capital Markets, Guggenheim Securities (60) Michael Jiang | LinkedIn)
• US Investor TBD
• Michael Chen, CEO, Nuclera

Agenda: 
8:30 am to 9:00 am:         Registration/breakfast
9:00 am to 10:00 am:       Program
10:00 am to 11:00 am:     Networking

Registration: 
Attendance at this event is free of charge and by invitation only.
To request an invitation, please email Tony Jones, One Nucleus, at your earliest convenience on tony@onenucleus.com.